Marketing authorisation

J&J likely to seek EU approval for Covid-19 vaccine in February, says lawmaker

US firm Johnson & Johnson is likely to apply for EU approval for its Covid-19 vaccine candidate in February, a top lawmaker said on Wednesday.

Clinical data of the vaccine, which Johnson & Johnson is developing through its subsidiary Janssen, have been assessed by the European Medicines Agency (EMA) since Dec. 1 under a rolling review to speed up possible approval.